Mesoblast Ltd (MESO)

12.09 +0.33 (+2.81%) USD  |  NASDAQ  |  Dec 16, 15:45
More

Mesoblast Max Drawdown (5Y): 95.66% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for MESO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cumulative Total Returns Versus Peers
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Alterity Therapeutics Ltd 96.94%
Kazia Therapeutics Ltd 98.69%
Immutep Ltd 96.60%
Opthea Ltd 92.46%
Immuron Ltd 92.60%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -51.05
Beta (5Y) 3.540
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 120.3%
Historical Sharpe Ratio (5Y) -0.0314
Historical Sortino (5Y) -0.0732
Monthly Value at Risk (VaR) 5% (5Y Lookback) 37.66%